Nitric Oxide, Atrial Natriuretic Peptide, and Cyclic GMP Inhibit the Growth-Promoting Effects of Norepinephrine in Cardiac Myocytes and Fibroblasts.

Journal of Clinical Investigation - United States
doi 10.1172/jci119883
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Adrenomedullin and Nitric Oxide Inhibit Human Endothelial Cell Apoptosis via a Cyclic GMP-Independent Mechanism

Hypertension
Internal Medicine
2000English

Pressure Dependence of Atrial Natriuretic Peptide During Norepinephrine Infusion in Humans

Hypertension
Internal Medicine
1987English

Effects of Atrial Natriuretic Peptide on Rat Ventricular Fibroblasts During Differentiation Into Myofibroblasts

Physiological Research
MedicinePhysiology
2015English

Comparative Effects of Several Nitric Oxide Donors on Intracellular Cyclic GMP Levels in Bovine Chromaffin Cells: Correlation With Nitric Oxide Production

British Journal of Pharmacology
Pharmacology
1999English

Renal and Cardiovascular Effects of Atrial Natriuretic Peptide in Fetal Sheep

Pediatric Research
Child HealthPediatricsPerinatology
1989English

Effects of Atrial Natriuretic Peptide in the Canine Coronary Circulation

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1988English

Plasma Atrial Natriuretic Peptide Concentration and Platelet Atrial Natriuretic Peptide Binding Site Density in Ageing and Hypertension

Clinical Science
1991English

Osteoclastic Inhibition: An Action of Nitric Oxide Not Mediated by Cyclic GMP.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Atrial Natriuretic Peptide and Blood Pressure

Mayo Clinic Proceedings
Medicine
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy